Company Filing History:
Years Active: 1998-2000
Title: **Innovator Spotlight: Peter Tijssen**
Introduction
Peter Tijssen, based in Pointe Claire, Canada, is a notable inventor recognized for his contributions to veterinary medicine. With a focus on vaccines, Tijssen holds two patents that demonstrate his commitment to providing innovative solutions for animal health.
Latest Patents
Tijssen's latest inventions include:
1. **Bovine Viral Diarrhea Virus II Vaccine and Method of Immunization** - This invention pertains to the identification of Bovine Viral Diarrhea Virus group II (BVDV-II) nucleic acid sequences such as gp53. It covers methods for detecting the BVD-II virus in animal sera and includes polypeptide viral antigens responsive to sera from animals infected with BVD-II. Moreover, it establishes polynucleotide sequences encoding these antigens, an expression system for their production, and vaccines that utilize these polypeptide antigens. Additionally, the patent includes methodologies for detecting BVD-II virus antibodies in animal sera and antibodies targeting these antigens.
2. **Immunogenic Composition Against Bovine Viral Diarrhea Virus II** - Similar to his previous patent, this invention further delves into the identification and application of BVDV-II nucleic acid sequences, polypeptide antigens, and their use in immunogenic compositions to enhance disease detection and prevention in affected animals.
Career Highlights
Peter Tijssen is currently associated with Biostar, Inc., a company focused on advanced biotechnological solutions for livestock health. His work there emphasizes the development of vaccines that are crucial for controlling viral infections in cattle.
Collaborations
At Biostar, Tijssen collaborates with Jan Van Den Hurk, working together to enhance the understanding of viral diseases in animals and improving vaccine efficacy. Their joint efforts are aimed at fostering better health outcomes in livestock populations.
Conclusion
Peter Tijssen's inventive spirit and dedication to veterinary medicine have positioned him as a key figure in the development of innovative vaccines. His patents not only highlight his technical expertise but also represent significant advancements in animal healthcare that could benefit the agricultural industry as a whole.